project id: TCGA-STAD; case submitter id: TCGA-VQ-A8PZ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; analyte type: DNA; analyte type id: D; experimental protocol type: aDNA Preparation Type; normal tumor genotype snp match: Yes; spectrophotometer method: PicoGreen; age at index: 56; days to birth: -20735; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 20735; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2233.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8490/3; primary diagnosis: Signet ring cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of stomach; synchronous malignancy: No; tissue or organ of origin: Body of stomach; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1786; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-VQ-A8PZ-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 65.0;